ASCEND GO-2: Study of RVT-1401 for the Treatment of Participants With Active, Moderate to Severe Graves' Ophthalmopathy ( GO )
Public ClinicalTrials.gov record NCT03938545. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
ASCEND GO-2: A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-controlled Study of RVT-1401 for the Treatment of Patients With Active, Moderate to Severe Graves' Ophthalmopathy
Study identification
- NCT ID
- NCT03938545
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Immunovant Sciences GmbH
- Industry
- Enrollment
- 65 participants
Conditions and interventions
Conditions
Interventions
- Placebo (Administered via subcutaneous injection) Other
- RVT-1401 (Administered via subcutaneous injection) Drug
Other · Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 22, 2019
- Primary completion
- Feb 1, 2021
- Completion
- Apr 14, 2021
- Last update posted
- Sep 21, 2022
2019 – 2021
United States locations
- U.S. sites
- 12
- U.S. states
- 11
- U.S. cities
- 12
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Multispecialty Aesthetic Clinical Research Organziation (MACRO) | Beverly Hills | California | 90212 | — |
| Doheny Eye Center UCLA | Pasadena | California | 91105 | — |
| University of Miami Miller School of Medicine Bascom Palmer Eye Institute | Miami | Florida | 33136 | — |
| University of Iowa Hospitals & Clinics - Eye Clinic | Iowa City | Iowa | 52242 | — |
| University of Michigan - Kellogg Eye Center | Ann Arbor | Michigan | 48105 | — |
| Mayo Clinic | Rochester | Minnesota | 55905 | — |
| Washington University School of Medicine - Center for Advanced Medicine (CAM) - Eye Center | St Louis | Missouri | 63146 | — |
| University of Rochester Medical Center | Rochester | New York | 14642 | — |
| Oregon Health & Science University (OHSU) - Casey Eye Institute (CEI)-Marquam Hill | Portland | Oregon | 97239 | — |
| Eye Wellness Center | Houston | Texas | 77005 | — |
| Eyelid Center of Utah | Salt Lake City | Utah | 84102 | — |
| West Virginia University Eye Institute | Morgantown | West Virginia | 26506 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 13 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03938545, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 21, 2022 · Synced May 17, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03938545 live on ClinicalTrials.gov.